and HPr-Independent Antitermination Affect Catabolite Repress

Download and HPr-Independent Antitermination Affect Catabolite Repress

Post on 14-Feb-2017




0 download

Embed Size (px)


<ul><li><p>JOURNAL OF BACTERIOLOGY, Sept. 2002, p. 48194828 Vol. 184, No. 170021-9193/02/$04.000 DOI: 10.1128/JB.184.17.48194828.2002Copyright 2002, American Society for Microbiology. All Rights Reserved.</p><p>Bacillus subtilis Mutant LicT Antiterminators Exhibiting Enzyme I- andHPr-Independent Antitermination Affect Catabolite Repression of</p><p>the bglPH OperonCordula Lindner,1,2 Michael Hecker,2 Dominique Le Coq,1 and Josef Deutscher1*</p><p>Laboratoire de Genetique des Microorganismes, INRA-CNRS, URA1925, F-78850 Thiverval-Grignon, France,1 and Institutfur Mikrobiologie und Molekularbiologie, Ernst-Moritz-Arndt-Universitat, D-17487 Greifswald, Germany2</p><p>Received 18 March 2002/Accepted 4 June 2002</p><p>The Bacillus subtilis antiterminator LicT regulates the expression of bglPH and bglS, which encode theenzymes for the metabolism of aryl--glucosides and the -glucanase BglS. The N-terminal domain of LicT(first 55 amino acids) prevents the formation of -independent terminators on the respective transcripts bybinding to target sites overlapping these terminators. Proteins of the phosphoenolpyruvate:carbohydratephosphotransferase system (PTS) regulate the antitermination activity of LicT by phosphorylating histidinesin its two PTS regulation domains (PRDs). Phosphorylation at His-100 in PRD-1 requires the PTS proteinsenzyme I and HPr and the phosphorylated permease BglP and inactivates LicT. During transport andphosphorylation of aryl--glucosides, BglP is dephosphorylated, which renders LicT active and thus leads tobglPH and bglS induction. In contrast, phosphorylation at His-207 and/or His-269 in PRD-2, which requiresonly enzyme I and HPr, is absolutely necessary for LicT activity and bglPH and bglS expression. We isolatedspontaneous licT mutants expressing bglPH even when enzyme I and HPr were absent (as indicated by thedesignation Pia [PTS-independent antitermination]). Introduced in a ptsHI strain, two classes of licT(Pia)mutations could be distinguished. Mutants synthesizing LicT(Pia) antiterminators altered in PRD-2 stillrequired induction by aryl--glucosides, whereas mutations affecting PRD-1 caused constitutive bglPH expres-sion. One of the two carbon catabolite repression (CCR) mechanisms operative for bglPH requires the-independent terminator and is probably prevented when LicT is activated by PHis-HPr-dependent phos-phorylation in PRD-2 (where the prefix P stands for phospho). During CCR, the small amount ofPHis-HPr present in cells growing on repressing PTS sugars probably leads to insufficient phosphorylationat PRD-2 of LicT and therefore to reduced bglPH expression. In agreement with this concept, mutantssynthesizing a PHis-HPr-independent LicT(Pia) had lost LicT-modulated CCR.</p><p>Bacillus subtilis LicT is an antiterminator of the BglG/SacYfamily regulating the expression of bglS, which forms anoperon together with licT, and of the bglPH operon (16, 25).bglP codes for an aryl--glucoside-specific enzyme, IIBCA;bglH codes for a 6-P--glucosidase (16); and bglS codes for anextracellular -glucanase (also called LicS) (21). LicT is com-posed of an N-terminal RNA binding domain (4) and tworegulatory domains controlled by proteins of the phosphoenol-pyruvate (PEP):carbohydrate phosphotransferase system(PTS). These two domains were therefore called PTS regula-tion domains (PRDs). The PTS proteins form a phosphoryla-tion cascade not only catalyzing the uptake and concomitantPEP-dependent phosphorylation of carbohydrates but alsoregulating numerous metabolic functions. The PTS is com-posed of the general proteins enzyme I and HPr and thesugar-specific enzyme II complexes (for a review, see reference23).</p><p>The crystal structure of the PRDs of LicT, which exhibitsignificant similarity to each other, has recently been resolved(34). Each PRD contains two conserved histidyl residues (100</p><p>and 159; 207 and 269), which are all phosphorylated by PEP,enzyme I, and HPr (18, 33). BglP, the aryl--glucoside-specificenzyme II, participates in bglPH (16) and probably also bglSinduction. PBglP (where the prefix P stands for phos-pho) is thought either to directly phosphorylate LicT at His-100 or to stimulate the PHis-HPr-mediated phosphorylationat this site (33). Replacing His-100 with a nonphosphorylatablealanine causes constitutive bglPH expression, suggesting thatphosphorylation at this position leads to inactivation of LicT.One model proposes that PBglP might also interact withLicT phosphorylated at His-100 (33) and thus prevent thebinding of LicT to its targets, the ribonucleic antitermination(RAT) sites (1) on the nascent bglPH and licT-bglS transcripts.If functional LicT is not available, terminator structures areformed on the mRNAs, leading to the synthesis of short tran-scripts, which in the case of bglPH are composed of only about110 nucleotides (14). In the presence of an aryl--glucoside,BglP is probably primarily present in its unphosphorylatedform, since the phosphoryl group accepted from PHis-HPr israpidly transferred to its sugar substrate. In the absence ofPBglP, LicT will not be phosphorylated at His-100. As aconsequence, the presence of aryl--glucosides allows the syn-thesis of full-length bglPH and bglS transcripts, as under theseconditions LicT can bind to the RAT sites and thus prevent theformation of the terminator partially overlapping the RATsequences. However, to be able to bind to its RAT sites, LicT</p><p>* Corresponding author. Mailing address: Laboratoire de Genet-ique des Microorganismes, INRA-CNRS URA1925, 78850 Thiverval-Grignon, France. Phone: 33-1-30815447. Fax: 33-1-30815457.</p><p> Present address: Friesland Coberco Dairy Foods Corporate Re-search, 7418 BA Deventer, The Netherlands.</p><p>4819</p><p> on April 12, 2018 by guest</p><p></p><p>Dow</p><p>nloaded from </p><p></p></li><li><p>needs first to be phosphorylated by PHis-HPr at His-207and/or His-269 in PRD-2. When this phosphorylation was pre-vented by either inactivating enzyme I (18) or HPr (14) or byreplacing His-207 and/or His-269 by alanines (33), the corre-sponding mutants were devoid of LicT antitermination activity.</p><p>Diminished phosphorylation in PRD-2 during the uptake ofa rapidly metabolizable carbohydrate such as glucose has beenproposed to play a role in one of the two carbon cataboliterepression (CCR) mechanisms controlling the bglPH operon(14). bglPH expression is regulated by catabolite control pro-tein A (CcpA)-mediated CCR, which is operative in mostgram-positive bacteria (6, 30). CcpA is a member of the LacI/GalR repressor family (11). It needs to form a complex with itscorepressor seryl-46-phosphorylated HPr (P-Ser-HPr) (7, 10)to be able to bind to most of its DNA targets, the cataboliteresponse elements (cre) (22) located in front or at the begin-ning of catabolite-repressed transcription units. The bifunc-tional HPr kinase/phosphatase (HprK/P)the sensor enzymeof CCR responding to changes in the concentration of ATP,glycolytic intermediates, and inorganic phosphatecatalyzesthe ATP-dependent phosphorylation of HPr at Ser-46 (8) aswell as the dephosphorylation of P-Ser-HPr (13) and thusindirectly regulates CcpA binding to its DNA targets. How-ever, B. subtilis ccpA mutants (15) or strains in which the bglPHcre was deleted (14) still exhibited four- to sevenfold repressionof the bglPH operon by glucose. This residual CCR disap-peared in mutants in which the terminator sequence precedingbglPH had been deleted (14, 15), suggesting that this secondCCR might be mediated by inactivation of LicT. The CcpA-independent CCR also disappeared in ptsH1 mutants, whichsynthesize S46A mutant HPr and which are therefore unableto form P-Ser-HPr (9). P-Ser-HPr is a poor substrate for thePEP-dependent phosphorylation by enzyme I (5). The uptakeof rapidly metabolizable PTS sugars by B. subtilis wild-typecells leads to high concentrations of P-Ser-HPr and thereforeto low amounts of PHis-HPr (20), the phosphoryl donor forLicT and the enzyme IIAs. As LicT is less efficiently phosphor-ylated than the enzyme IIAs (18), it will be present primarily inits unphosphorylated, inactive form when a PTS sugar is trans-ported and phosphorylated, which leads to reduced expressionof the bglPH operon. The inability of ptsH1 mutants to produceP-Ser-HPr was assumed to allow these strains to form sufficientPHis-HPr to effectively phosphorylate LicT even when arapidly metabolizable PTS sugar is taken up, thus preventingCcpA-independent CCR.</p><p>Two classes of PRD-containing antiterminators exist in bac-teria. Antiterminators of the first class, including LicT, arecontrolled by the PTS in an antagonistic manner: negatively viathe respective substrate-specific enzyme II of the PTS atPRD-1 and positively via the general PTS protein HPr atPRD-2. In contrast, antiterminators of the second class, includ-ing SacY and GlcT of B. subtilis, are only negatively controlledby the PTS (for reviews, see references 6 and 29). They arefunctional without PHis-HPr-mediated phosphorylation intheir PRD-2 and are therefore naturally PTS independent (2,31). As a consequence, SacY and GlcT do not exhibit antiter-mination-mediated CCR, and interestingly, the transcriptionunits controlled by SacY and GlcT, sacB and ptsGHI, are alsonot subject to CCR via CcpA. In order to better understandthe molecular details of the stimulating effect caused by phos-</p><p>phorylation at PRD-2 in LicT, we attempted to obtain PHis-HPr-independent mutant LicT antiterminators resembling thenaturally PTS-independent antiterminators SacY and GlcT. Bysetting up an appropriate screening system, we were indeedable to isolate several licT(Pia) mutants (Pia stands forPTS-independent antitermination). The effect of these mu-tations on LicT activity, antitermination-mediated CCR, andinducibility will be discussed in light of the recently determinedcrystal structure of the PRDs of LicT (34).</p><p>MATERIALS AND METHODS</p><p>Strains, growth conditions, and transformation procedures. The B. subtilisstrains used in this study are listed in Table 1. They were grown in Luria-Bertani(LB) medium or in minimal medium of the following composition: 50 mMTris-HCl buffer (pH 7.5), 15 mM (NH4)2SO4, 8 mM MgSO4, 27 mM KCl, 7 mMNa3-citrate, 0.4 mM KH2PO4, 2 mM CaCl2, 1 mM FeSO4, 10 mM MnSO4, 4.5mM K-glutamate, and 0.1% ribose. To obtain solid media, 1.5% agarose wasadded to LB or minimal medium. To transform Escherichia coli NM522 and thevarious B. subtilis strains, we followed previously described procedures (12, 24).To select transformants, the following antibiotics were added to the growthmedia at the indicated concentrations as appropriate: chloramphenicol, 5 g/ml;kanamycin, 10 g/ml; neomycin, 20 g/ml; spectinomycin, 100 g/ml; and phleo-mycin, 0.2 g/ml (for B. subtilis) and ampicillin, 100 g/ml; chloramphenicol,30 g/ml; spectinomycin, 150 g/ml; and kanamycin, 25 g/ml (for E. coli).When indicated, X-Gal (5-bromo-4-chloro-3-indolyl--D-galactopyranoside) waspresent at a final concentration of 40 g/ml.</p><p>-Galactosidase assays. To carry out -galactosidase tests, B. subtilis cellswere grown in 0.1% ribose-containing minimal medium. When indicated, 0.05%salicin was added to induce bglPH expression, whereas 0.2% glucose was addedto elicit CCR. When the cultures had reached an optical density at 550 nm of 0.8to 1.0, cells were harvested and -galactosidase activities were measured aspreviously described (19). Three to five independent experiments were carriedout, and their mean values are presented.</p><p>Oligonucleotides and PCR. To amplify the various licT(Pia) alleles, PCRswere carried out using oligonucleotides LicSma, 5-d(CAAAAACAGCCCGGGCAGC)-3, and LicTrev, 5-d(CCTACCATTTTCATATGTGAATG)-3, asprimers. Amplification of DNA fragments from chromosomal DNA of the var-ious licT(Pia) mutants was carried out in a total volume of 100 l containing 1 gof template DNA, a 200 M concentration of each deoxynucleoside triphos-phate, 50 pmol of each primer, and 2.5 U of Taq polymerase (Stratagene). Thesamples were covered with 60 l of light mineral oil, and usually 20 cycles ofamplification were run.</p><p>Plasmid constructions. Plasmids used in this study are listed in Table 1. Tointegrate the promoterless kanamycin-neomycin resistance gene aphA3 fused tobglH into the chromosomal bglPH locus of B. subtilis strains, plasmid pCL18 wasconstructed by first cloning the 2.1-kb NotI-HindIII fragment of pIC254 (26),which contains the 3 part of bglP and nearly the entire bglH, into pIC408 cut withthe same enzymes. pIC408 is an integrative plasmid for B. subtilis that carries aColEI origin, the multiple cloning site of pBluescript II SK(), and a spectino-mycin resistance gene, allowing selection in E. coli and B. subtilis. A 1.5-kbHindII fragment containing the phleomycin resistance gene of pIC22 (27) wasused to replace the 495-bp SmaI-StuI fragment of bglH in the pIC254/pIC408-derived plasmid before a 1.4-kb HindII-RsaI fragment of pIC239 containing thepromoterless aphA3 gene was inserted into its EcoRV site (17). The resultingplasmid was called pCL18 and carried a bglPH-aphA3 transcriptional fusion. InpCL18, the neomycin and the following phleomycin resistance gene are tran-scribed in the same direction. They are preceded by a 1-kb bglPH and followedby a 0.5-kb bglH fragment from B. subtilis. Since the two antibiotic resistancecassettes are separated by only 100 bp, they could be simultaneously integratedinto bglPH of the B. subtilis chromosome, leaving the bglP gene intact anddisrupting only bglH and therefore leading to aryl--glucoside-inducible neomy-cin resistance.</p><p>To construct plasmid pCL46, plasmid pSL3 (15) was cut with SmaI to removea 1.5-kb fragment containing the cat gene. The shortened pSL3 was subsequentlyreligated and cut with NruI/EcoRV, and the resulting 2.8-kb fragment was ligatedwith a 5-kb EcoRI fragment from pIC254, providing plasmid pCL46. Beforecarrying out this ligation, the 5-kb EcoRI fragment had been treated with theKlenow fragment of DNA polymerase I.</p><p>Selection of licT(Pia) mutants. Strain BGC12 was constructed by integratingthe bglP-lacZ fusion present in ScaI-linearized plasmid pSL3 into the amyE</p><p>4820 LINDNER ET AL. J. BACTERIOL.</p><p> on April 12, 2018 by guest</p><p></p><p>Dow</p><p>nloaded from </p><p></p></li><li><p>locus of GM1210, a B. subtilis strain devoid of the antiterminators SacY and SacTand of the -galactosidase LacA (formerly BgaX). After transformation ofBGC12 with plasmid pCL18, phleomycin-resistant integrants were isolated andscreened for spectinomycin sensitivity. Phleomycin-resistant and spectinomycin-sensitive clones were expected to contain a transcriptional fusion between thepromoterless aphA3 gene and bglH. One integrant, called BGC13, was isolated.The presence of salicin in the growth medium conferred neomycin resistance tothis strain as well as the ability to form blue colonies on X-Gal plates. Theisogenic tetracycline-resistant ptsGHI strain BGC14 was constructed by trans-forming BGC13 with chromosomal DNA of strain GM1220 carrying a tetracy-cline resistance cassette integrated in...</p></li></ul>


View more >